跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 165 条关于
“EGRIFTA SV”
全部
165
临床试验
58
药物
37
机构
2
资讯
68
去年
Theratechnologies Awaits FDA Decision on EGRIFTA SV® Manufacturing Change
去年
Theratechnologies Launches EGRIFTA WR, First Weekly Formulation for HIV-Associated Lipodystrophy
去年
FDA Approves Theratechnologies' EGRIFTA SV Prior Approval Supplement and Alpha Tau's Trial for Recurrent Glioblastoma
去年
FDA Approves EGRIFTA WR™: New Weekly Reconstitution Formulation for HIV-Associated Lipodystrophy
去年
SYNC-T SV-102 Shows Promising Response in Metastatic Castration-Resistant Prostate Cancer
去年
Dementia Discovery Fund Secures $269M in Second Fund to Accelerate Novel Therapeutics Development
10个月前
Syncromune's SYNC-T Therapy Shows Bone Metastases Resolution in Phase 1 Prostate Cancer Trial
3个月前
AdvanCell Raises $315M Series D to Advance Targeted Alpha Radiopharmaceuticals for Cancer
4个月前
Syncromune's SYNC-T Therapy Shows 87% Response Rate in Metastatic Prostate Cancer Phase 1 Trial
10个月前
Artios Pharma Raises $115M Series D to Advance DNA Damage Response Cancer Therapies
第 1 页,共 7 页
上一页
下一页